Xiao-lin Yu
National Key Laboratory Of Biopharmaceutical Preparation And Delivery
Haidian, 100190, China
Haidian, 100190, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
An Engineered Multifunctional Fusion Protein Targeting Aβ Oligomers, Microglia and Autophagy Ameliorates Cognitive Deficits and Amyloid Pathology in Alzheimer's Disease Mice.
Journal: Cellular and molecular neurobiology
Published: February 03, 2026
Targeted phagocytosis of TNF-α by CAR macrophages restores immune homeostasis in arthritis.
Journal: Theranostics
Published: January 26, 2026
Retraction Note: Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific ScFv antibody and class A scavenger receptor activator show therapeutic potentials for alzheimer's disease.
Journal: Journal of nanobiotechnology
Published: November 26, 2025
Fc-Modified IVIG with Enhanced Blood-Brain Barrier Penetration Ameliorates Cognitive Deficits and Neuropathology in A53T α-Synuclein Transgenic Mice.
Journal: Cellular and molecular neurobiology
Published: August 12, 2025
Attenuating α-synuclein pathology in mice with in situ engineered astrocytes.
Journal: Translational neurodegeneration
Published: October 11, 2024
Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration.
Journal: Translational neurodegeneration
Published: January 01, 2024
Mouse serum albumin induces neuronal apoptosis and tauopathies.
Journal: Acta neuropathologica communications
Published: December 04, 2023
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model.
Journal: Signal transduction and targeted therapy
Published: July 25, 2022
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
Journal: Journal of neuroinflammation
Published: March 01, 2021
Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer's Disease.
Journal: Journal of nanobiotechnology
Published: June 24, 2020
The immunodominant and neutralization linear epitopes for SARS-CoV-2.
Journal: Cell reports
Published: June 09, 2020
Ellagic acid rescues motor and cognitive deficits in the R6/2 mouse model of Huntington's disease by lowering mutant huntingtin protein.
Journal: Food & function
Published: February 12, 2020
Last Updated: 09/26/2026